Seroatlas · Human Serome Atlas

MEF2A

Myocyte-specific enhancer factor 2A

Also known as: MEF2A_HUMAN, RSRFC4, RSRFC9

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
Q02078
Gene
MEF2A
Ensembl
ENSG00000068305
Chromosome
15
Canonical length
507 aa
Protein class
Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors
Subcellular location
Nucleoplasm,Cytosol

OverviewNCBI Gene

The protein encoded by this gene is a DNA-binding transcription factor that activates many muscle-specific, growth factor-induced, and stress-induced genes. The encoded protein can act as a homodimer or as a heterodimer and is involved in several cellular processes, including muscle development, neuronal differentiation, cell growth control, and apoptosis. Defects in this gene could be a cause of autosomal dominant coronary artery disease 1 with myocardial infarction (ADCAD1). Several transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Jan 2010]

Canonical amino-acid sequenceUniProt

507 residues, UniProt reviewed canonical sequence.

>Q02078|MEF2A
     1  MGRKKIQITR IMDERNRQVT FTKRKFGLMK KAYELSVLCD CEIALIIFNS SNKLFQYAST
    61  DMDKVLLKYT EYNEPHESRT NSDIVEALNK KEHRGCDSPD PDTSYVLTPH TEEKYKKINE
   121  EFDNMMRNHK IAPGLPPQNF SMSVTVPVTS PNALSYTNPG SSLVSPSLAA SSTLTDSSML
   181  SPPQTTLHRN VSPGAPQRPP STGNAGGMLS TTDLTVPNGA GSSPVGNGFV NSRASPNLIG
   241  ATGANSLGKV MPTKSPPPPG GGNLGMNSRK PDLRVVIPPS SKGMMPPLSE EEELELNTQR
   301  ISSSQATQPL ATPVVSVTTP SLPPQGLVYS AMPTAYNTDY SLTSADLSAL QGFNSPGMLS
   361  LGQVSAWQQH HLGQAALSSL VAGGQLSQGS NLSINTNQNI SIKSEPISPP RDRMTPSGFQ
   421  QQQQQQQQQQ PPPPPQPQPQ PPQPQPRQEM GRSPVDSLSS SSSSYDGSDR EDPRGDFHSP
   481  IVLGRPPNTE DRESPSVKRM RMDAWVT

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against MEF2A can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Intracellular
Secreted
No
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.67
Highest tissue expression
88 nTPM

Expression across tissuesHPA

Tissue

  • heart muscle: 88 nTPM
  • tongue: 79 nTPM
  • skeletal muscle: 58 nTPM
  • skin: 52 nTPM
  • blood vessel: 48 nTPM
  • cerebral cortex: 41 nTPM

Single-cell type

  • microglia: 3,037 nCPM
  • neutrophils: 1,664 nCPM
  • myonuclei: 925 nCPM
  • endometrial luminal cells: 873 nCPM
  • macrophages: 824 nCPM
  • neutrophil progenitors: 671 nCPM

Immune cell

  • non-classical monocyte: 23 nTPM
  • memory B-cell: 18 nTPM
  • intermediate monocyte: 17 nTPM
  • eosinophil: 16 nTPM
  • myeloid DC: 14 nTPM
  • classical monocyte: 13 nTPM

Brain region

  • thalamus: 84 nTPM
  • cerebral cortex: 81 nTPM
  • white matter: 80 nTPM
  • midbrain: 69 nTPM
  • spinal cord: 65 nTPM
  • amygdala: 64 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about MEF2A.

Disease | AllUniProt

Conditions MEF2A is implicated in, by any mechanism.

Disease | GeneticClinVar

3 pathogenic / likely-pathogenic of 76 ClinVar records.

Conditions with pathogenic or likely-pathogenic variants.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
0.29
gnomAD pLI
0.99
gnomAD missense Z
1.54
DepMap mean gene effect
0.03
DepMap dependency class
none

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of MEF2A in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads MEF2A as an antibody target. Whether an autoantibody or antibody against MEF2A could matter depends on whether native MEF2A is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

MEF2A is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.

Annotation status

The present source text does not explicitly label MEF2A as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/MEF2A. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...